Literature DB >> 24355452

Successful breast reconstruction using acellular dermal matrix can be recommended in healthy non-smoking patients.

Gudjon Leifur Gunnarsson1, Mikkel Børsen-Koch, Susanne Arffmann, Ivar Guldvog, Peter Wamberg, Christina Kjær, Tormod Westvik, Jørn Bo Thomsen.   

Abstract

INTRODUCTION: We present Scandinavia's first series of immediate alloplastic breast reconstructions with an acellular dermal matrix.
MATERIAL AND METHODS: Data were collected retrospectively in 76 cases of immediate breast reconstruction using an acellular dermal matrix (ADM) and an implant.
RESULTS: A total of 59 women were reconstructed between June 2011 and January 2013. Cases included 42 unilateral and 17 bilateral reconstructions. A large number of patients had adjuvant therapy, hormone therapy (34), radiation therapy (27) or chemotherapy (38). The median age was 51 years (30-70 years) and the median follow-up period was 326 days (68-624 days). The co-morbidity factors included hypertension (n = 11), diabetes (n = 2) and 19 patients were smokers. Unsuccessful reconstructions counted ten cases (13%), eight of these due to necrosis and/or wound dehiscence (10%) and two due to infection (3%). The failure rate in non-smokers was 2/52 (4%) compared with 8/24 (33%) in smokers, p = 0.001. In hypertensive patients, the failure rate was 6/12 (50%) compared with 4/64 (6%)in normotensive patients, p = 0.001. 70% of the failed reconstructions occurred in patients older than 65 years of age.
CONCLUSION: Immediate alloplastic breast reconstruction using an ADM can be recommended to healthy non-smoking patients. FUNDING: not relevant. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Year:  2013        PMID: 24355452

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  9 in total

1.  Visualized pre- and subpectoral implant placement for immediate breast reconstruction.

Authors:  Diana L Dyrberg; Camilla Bille; Gudjon L Gunnarsson; Jens A Sørensen; Jørn B Thomsen
Journal:  Gland Surg       Date:  2019-10

2.  DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review.

Authors:  Austin R Swisher; Mark J Landau; Nikita Kadakia; Stephanie W Holzmer; Hahns Y Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-20

3.  How to perform a NAC sparing mastectomy using an ADM and an implant.

Authors:  Gudjon Leifur Gunnarsson; Mikkel Børsen-Koch; Peter Wamberg; Jørn Bo Thomsen
Journal:  Gland Surg       Date:  2014-11

Review 4.  Acellular dermal matrices and radiotherapy in breast reconstruction: a systematic review and meta-analysis of the literature.

Authors:  Luigi Valdatta; Anna Giulia Cattaneo; Igor Pellegatta; Stefano Scamoni; Anna Minuti; Mario Cherubino
Journal:  Plast Surg Int       Date:  2014-05-21

5.  A Complication Analysis of 2 Acellular Dermal Matrices in Prosthetic-based Breast Reconstruction.

Authors:  Orion P Keifer; Eugenia K Page; Alexandra Hart; Randall Rudderman; Grant W Carlson; Albert Losken
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-07-13

6.  Comparing the Outcome of Different Biologically Derived Acellular Dermal Matrices in Implant-based Immediate Breast Reconstruction: A Meta-analysis of the Literatures.

Authors:  Yew L Loo; Pragash Kamalathevan; Peng S Ooi; Afshin Mosahebi
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-03-19

7.  The Use of Porcine Acellular Dermal Matrix in Single-stage, Implant-based Immediate Breast Reconstruction: A 2-center Retrospective Outcome Study.

Authors:  Yew L Loo; Sajjad Haider
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-08-06

8.  Prepectoral Hammock and Direct-to-implant Breast Reconstruction in 10 Minutes: A Focus on Technique.

Authors:  Gudjon L Gunnarsson; Jorn Bo Thomsen
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-10-02

9.  Direct-to-Implant Extracellular Matrix Hammock-based Breast Reconstruction; Prepectoral or Subpectoral?

Authors:  Diana L Dyrberg; Gudjon L Gunnarsson; Camilla Bille; Jens A Sørensen; Jørn B Thomsen
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.